Schedule 13G ownership disclosure

THERAPEUTICSMD INC

Security class unavailable · CUSIP: 88338N107

Event date: 2016-12-30

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
5,786,428
Percent of class
2.9400%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000902219-17-000396
Form type
SC 13G/A
Filer
TherapeuticsMD, Inc.
CIK
CIK 25743
Filed
Feb 09, 2017
Reporting period
Dec 30, 2016
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub